Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of 13vPnC in Healthy Infants in China
CTR20130331Phase 3Completed
- Sponsor
- Wyeth
- Start
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in invasive pneumococcal disease (IPD), sponsored by Wyeth. Started Mar 2015; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on CTR20130331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130331.